GNH USA

Europe — EMA

Nelova (Ethinylestradiol, Etonogestrel)

GNH USA supplies Nelova (Ethinylestradiol/Etonogestrel), an estrogen‑progestogen contraceptive for preventing pregnancy. Request a quote for global supply.

Ethinylestradiol, Etonogestrel

Request sourcing

1
Pack/s

What is Ethinylestradiol, Etonogestrel?

Ethinylestradiol/Etonogestrel, the active ingredient in Nelova, is a combined estrogen‑progestogen contraceptive presented as a vaginal ring for vaginal use. It provides reversible contraception for women of reproductive age.

GNH USA supplies Nelova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ethinylestradiol, Etonogestrel used for?

Nelova, a combined estrogen‑progestogen contraceptive, is indicated for prevention of pregnancy.

Contraception: provides reliable, reversible birth control for women of childbearing potential. Menstrual cycle regulation: helps establish a more predictable menstrual pattern. Reduced menstrual bleeding: may lessen the volume of menstrual blood loss.

What are the side effects of Ethinylestradiol, Etonogestrel?

Nelova may cause a range of adverse reactions.

Common Side Effects: - Headache - Nausea or vomiting - Breast tenderness - Mood changes or irritability - Vaginal irritation or discharge - Spotting between periods

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Stroke or transient ischemic attack - Myocardial infarction - Severe allergic reaction (anaphylaxis) - Liver tumor or severe hepatic dysfunction - Elevated blood pressure or hypertension crisis

What precautions apply to Ethinylestradiol, Etonogestrel?

Before prescribing Nelova, clinicians should evaluate individual risk factors. - Assess thrombotic risk: avoid in women with a history of venous thromboembolism. - Screen for hypertension: monitor blood pressure regularly. - Review smoking status: contraindicated in smokers over 35 years. - Evaluate liver function: avoid in severe hepatic disease. - Consider drug interactions: review concomitant enzyme‑inducing medications. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

What does Ethinylestradiol, Etonogestrel interact with?

Nelova can interact with several medication classes.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce contraceptive efficacy. - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase hormone exposure and risk of side effects.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly lower effectiveness. - Anticonvulsants (e.g., phenytoin, phenobarbital): may decrease hormone levels. - Herbal supplements (e.g., St. John’s wort): may reduce contraceptive reliability.

Frequently asked questions

What is Nelova used for?+
Nelova is a prescription vaginal ring that delivers a combined estrogen‑progestogen formulation to prevent pregnancy. It is intended for use by women of reproductive age who seek a reversible, long‑acting contraceptive method.
How does Ethinylestradiol/Etonogestrel work in Nelova?+
The ring releases ethinyloestradiol and etonogestrel, which suppress the release of follicle‑stimulating and luteinizing hormones, thereby inhibiting ovulation. The progestogen also thickens cervical mucus and alters the endometrial lining, creating multiple barriers to fertilisation and implantation.
What is the usual dose of Nelova?+
Nelova is supplied as a pre‑filled vaginal ring that is inserted by the user and left in place for three weeks, followed by a one‑week ring‑free interval. The exact dosing schedule is determined by the prescribing clinician based on individual health factors.
Is Nelova safe to use during pregnancy or breastfeeding?+
Nelova is contraindicated during pregnancy because it is intended to prevent conception. If pregnancy occurs, the ring should be removed immediately. Use during breastfeeding is generally not recommended without medical advice, as hormonal exposure may affect milk production.
How do I order Nelova from GNH USA?+
To request Nelova, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nelova compare with other combined hormonal contraceptives?+
Nelova delivers hormones via a vaginal ring, offering steady plasma levels and a three‑week wear schedule, unlike daily oral pills that require strict adherence. Compared with transdermal patches, the ring is less visible and may cause fewer skin‑related reactions, while providing comparable contraceptive efficacy.
What are the storage requirements for Nelova?+
Nelova should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from direct sunlight, moisture and excessive heat to maintain its integrity throughout its shelf life.
How is Nelova administered?+
The ring is inserted into the vagina by the user or a healthcare professional and left in place for three consecutive weeks. After a one‑week break, a new ring is inserted to continue contraception. No additional dosing is required during the wear period.
What are the most serious risks associated with Nelova?+
Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe allergic reactions, and hepatic disorders. Women with a history of clotting disorders, smoking over age 35, uncontrolled hypertension, or certain liver diseases should avoid using Nelova.
Who should not use Nelova?+
Nelova is contraindicated in women with a known or suspected pregnancy, active or past thromboembolic disease, uncontrolled hypertension, severe liver disease, breast cancer, or in smokers over 35 years of age. It should also be avoided in individuals with known hypersensitivity to any component of the ring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ethinylestradiol, Etonogestrel
Route
Vaginal Use
Manufacturer
Laboratoires Bailleul S.A.
Origin
EU

Related products

Adalina

Adalina

Ethinylestradiol, Etonogestrel

Biomo Pharma Gmbh
EU
Adaring

Adaring

Ethinylestradiol, Etonogestrel

Adamed Pharma S.A.
EU
Anette

Anette

Ethinylestradiol, Etonogestrel

Lifewell - Pharmaceutical & Healthcare, Lda.
EU
Circlet

Circlet

Ethinylestradiol, Etonogestrel

Organon Belgium B.V.
EU